Low-dose dynamic myocardial perfusion imaging by CZT-SPECT in the identification of obstructive coronary artery disease.


Journal

European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988

Informations de publication

Date de publication:
07 2020
Historique:
received: 01 08 2019
accepted: 28 11 2019
pubmed: 19 12 2019
medline: 28 4 2021
entrez: 19 12 2019
Statut: ppublish

Résumé

We measured myocardial blood flow (MBF) and myocardial perfusion reserve (MPR) by a dynamic low-dose CZT-SPECT protocol in patients with suspected or known coronary artery disease (CAD) and investigated the capability of dynamic data in predicting obstructive CAD. A total of 173 patients with suspected or known CAD underwent dynamic CZT-SPECT after the injection of 155 MBq and 370 MBq of Global MPR was lower (p < 0.05) in patients with abnormal compared with those with normal MPI (2.40 ± 0.7 vs. 2.70 ± 0.8). A weak, albeit significant correlation between TPD and MPR (r = - 0.179, p < 0.05) was found. In 91 patients with available angiographic data, hyperemic MBF (2.59 ± 1.2 vs. 3.24 ± 1.1 ml/min/g) and MPR (1.96 ± 0.7 vs. 2.74 ± 0.9) were lower (both p < 0.05) in patients with obstructive CAD (n = 21) compared with those without (n = 70). At univariable analysis, TPD, hyperemic MBF, and MPR were significant predictors of obstructive CAD, whereas only MPR was independent predictor at multivariable analysis (p < 0.05). At per vessels analysis, regional hyperemic MBF (2.59 ± 1.2 vs. 3.24 ± 1.1 ml/min/g) and regional MPR (1.96 ± 0.7 vs. 2.74 ± 0.9) were lower in the 31 vessels with obstructive CAD compared with 242 vessels without (both p < 0.05). In patients with suspected or known CAD, MPR assessed by low-dose dynamic CZT-SPECT showed a good correlation with myocardial perfusion imaging findings and it could be useful to predict obstructive CAD.

Sections du résumé

BACKGROUND
We measured myocardial blood flow (MBF) and myocardial perfusion reserve (MPR) by a dynamic low-dose CZT-SPECT protocol in patients with suspected or known coronary artery disease (CAD) and investigated the capability of dynamic data in predicting obstructive CAD. A total of 173 patients with suspected or known CAD underwent dynamic CZT-SPECT after the injection of 155 MBq and 370 MBq of
RESULTS
Global MPR was lower (p < 0.05) in patients with abnormal compared with those with normal MPI (2.40 ± 0.7 vs. 2.70 ± 0.8). A weak, albeit significant correlation between TPD and MPR (r = - 0.179, p < 0.05) was found. In 91 patients with available angiographic data, hyperemic MBF (2.59 ± 1.2 vs. 3.24 ± 1.1 ml/min/g) and MPR (1.96 ± 0.7 vs. 2.74 ± 0.9) were lower (both p < 0.05) in patients with obstructive CAD (n = 21) compared with those without (n = 70). At univariable analysis, TPD, hyperemic MBF, and MPR were significant predictors of obstructive CAD, whereas only MPR was independent predictor at multivariable analysis (p < 0.05). At per vessels analysis, regional hyperemic MBF (2.59 ± 1.2 vs. 3.24 ± 1.1 ml/min/g) and regional MPR (1.96 ± 0.7 vs. 2.74 ± 0.9) were lower in the 31 vessels with obstructive CAD compared with 242 vessels without (both p < 0.05).
CONCLUSIONS
In patients with suspected or known CAD, MPR assessed by low-dose dynamic CZT-SPECT showed a good correlation with myocardial perfusion imaging findings and it could be useful to predict obstructive CAD.

Identifiants

pubmed: 31848673
doi: 10.1007/s00259-019-04644-6
pii: 10.1007/s00259-019-04644-6
doi:

Substances chimiques

Technetium Tc 99m Sestamibi 971Z4W1S09

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1705-1712

Auteurs

Wanda Acampa (W)

Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy.
Institute of Biostructure and Bioimaging, National Council of Research, Naples, Italy.

Roberta Assante (R)

Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy.

Teresa Mannarino (T)

Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy.

Emilia Zampella (E)

Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy.

Adriana D'Antonio (A)

Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy.

Pietro Buongiorno (P)

Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy.

Valeria Gaudieri (V)

Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy.

Carmela Nappi (C)

Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy.

Alessia Giordano (A)

Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy.

Ciro Gabriele Mainolfi (CG)

Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy. c.mainolfi@libero.it.

Mario Petretta (M)

Department of Translational Medical Sciences, University Federico II, Naples, Italy.

Alberto Cuocolo (A)

Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH